1. | | Recruiting | Oral Enzastaurin HCl in Patients with Relapsed Mantle Cell Lymphoma Condition: Mantle-Cell Lymphoma |
2. | | Recruiting | Oblimersen, Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma Conditions: recurrent adult diffuse large cell lymphoma; recurrent mantle cell lymphoma; recurrent grade 3 follicular lymphoma |
3. | | Recruiting | CCI-779 in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia Conditions: refractory chronic lymphocytic leukemia; recurrent adult diffuse large cell lymphoma; recurrent adult Hodgkin's lymphoma |
4. | | Recruiting | Comparison of Two Induction Combination Chemotherapy Regimens Followed By High-Dose Consolidation Chemotherapy and Autologous Stem Cell Transplantation With or Without Rituximab as Maintenance Therapy in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's Lymphoma Condition: recurrent adult diffuse large cell lymphoma |
5. | | Recruiting | Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Oblimersen in Treating Patients With Advanced Diffuse Large B-Cell Non-Hodgkin's Lymphoma Conditions: contiguous stage II adult diffuse large cell lymphoma; noncontiguous stage II adult diffuse large cell lymphoma; ... |
6. | | Recruiting | Comparison of Two Salvage Chemotherapy Regimens Before Autologous Stem Cell Transplantation With or Without Maintenance Rituximab in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma Conditions: anaplastic large cell lymphoma; recurrent adult Burkitt's lymphoma; recurrent adult diffuse large cell lymphoma; angioimmunoblastic T-cell lymphoma |
7. | | Not yet recruiting | Comparative Trial between Bexxar and Zevalin Conditions: Follicular Lymphoma; Diffuse Large Cell Lymphoma |
8. | | Recruiting | FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin’s Lymphoma Conditions: recurrent adult diffuse large cell lymphoma; recurrent mantle cell lymphoma |
9. | | Recruiting | Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's Lymphoma Conditions: recurrent adult diffuse large cell lymphoma; recurrent adult immunoblastic large cell lymphoma; anaplastic large cell lymphoma |
10. | | Recruiting | Oblimersen, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma Conditions: contiguous stage II adult diffuse large cell lymphoma; noncontiguous stage II adult diffuse large cell lymphoma; ... |
11. | | Recruiting | Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First Relapse Conditions: recurrent adult diffuse large cell lymphoma; anaplastic large cell lymphoma; recurrent adult diffuse mixed cell lymphoma; ... |
12. | | Recruiting | Bortezomib in Treating Patients With Diffuse Large B-Cell Lymphoma That Is Refractory To Chemotherapy Condition: recurrent adult diffuse large cell lymphoma |
13. | | Recruiting | Combination Chemotherapy With or Without Rituximab in Treating Patients With Non-Hodgkin's Lymphoma Conditions: stage I adult diffuse large cell lymphoma; contiguous stage II adult diffuse large cell lymphoma; ... |
14. | | Recruiting | Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma Conditions: recurrent adult diffuse large cell lymphoma; recurrent adult diffuse mixed cell lymphoma; recurrent adult immunoblastic large cell lymphoma |
15. | | Recruiting | MDX-060 Monoclonal Antibody in Treating Patients With Refractory or Relapsed Lymphoma Conditions: recurrent adult Hodgkin's lymphoma; recurrent/refractory childhood Hodgkin's lymphoma; anaplastic large cell lymphoma; ... |
16. | | Recruiting | Rituximab and Combination Chemotherapy Combined With Yttrium Y 90 Ibritumomab Tiuxetan in Treating Older Patients With Previously Untreated B-Cell Lymphoma Conditions: noncontiguous stage II adult diffuse large cell lymphoma; stage III adult diffuse large cell lymphoma; stage IV adult diffuse large cell lymphoma |
17. | | Recruiting | Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Older Patients With Previously Untreated Non-Hodgkin's Lymphoma Conditions: contiguous stage II adult diffuse large cell lymphoma; noncontiguous stage II adult diffuse large cell lymphoma; ... |
18. | | Recruiting | BMS-247550 in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma Conditions: recurrent grade 3 follicular lymphoma; recurrent adult diffuse large cell lymphoma; recurrent adult diffuse mixed cell lymphoma; ... |
19. | | Recruiting | Bortezomib With or Without Combination Chemotherapy in Treating Patients With Relapsed or Refractory Lymphoma Conditions: recurrent adult diffuse large cell lymphoma; recurrent grade 3 follicular lymphoma |
20. | | Recruiting | Molecular Risk Assessment in Planning Treatment for Patients With Non-Hodgkin's Lymphoma Conditions: adult diffuse large cell lymphoma; childhood diffuse large cell lymphoma; childhood large cell lymphoma |
21. | | Recruiting | LY317615 in Treating Patients With Relapsed or Refractory Lymphoma Condition: recurrent adult diffuse large cell lymphoma |
22. | | Recruiting | Chemotherapy Plus Rituximab in Treating Patients With Mantle Cell Lymphoma Conditions: stage III mantle cell lymphoma; stage IV mantle cell lymphoma; stage II mantle cell lymphoma |
23. | | Recruiting | Combination Chemotherapy in Treating Older Patients With Non-Hodgkin's Lymphoma Conditions: stage I adult diffuse large cell lymphoma; stage III adult diffuse large cell lymphoma; stage IV adult diffuse large cell lymphoma; ... |
24. | | Recruiting | Chemotherapy and Rituximab With or Without Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma Conditions: stage I adult diffuse large cell lymphoma; stage III adult diffuse large cell lymphoma; stage IV adult diffuse large cell lymphoma; ... |
25. | | Recruiting | Study Of Yttrium-ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell Lymphoma Condition: Lymphoma, Mantle-Cell |
26. | | Recruiting | Selective T-Cell Depletion to Reduce Graft-Versus-Host-Disease in Patients Receiving Stem Cell Transplantation to Treat Leukemia, Lymphoma or Myelodysplastic Syndromes Conditions: Graft vs Host Disease; Myelodysplastic Syndromes; Leukemia; Leukemia, Myeloid; Leukemia, Myelomonocytic, chronic; Leukemia, Lymphocytyc; Lymphoma; ... |
27. | | Recruiting | Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma Conditions: recurrent adult diffuse large cell lymphoma; recurrent adult Burkitt's lymphoma; recurrent mantle cell lymphoma; anaplastic large cell lymphoma |
28. | | Recruiting | Chemotherapy and Peripheral Stem Cell Transplantation With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma Conditions: recurrent grade 3 follicular lymphoma; recurrent adult diffuse large cell lymphoma |
29. | | Recruiting | Monoclonal Antibody Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Conditions: recurrent adult diffuse mixed cell lymphoma; recurrent adult diffuse large cell lymphoma; recurrent adult immunoblastic large cell lymphoma |
30. | | Recruiting | Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma Conditions: adult Burkitt's lymphoma; adult diffuse large cell lymphoma; adult diffuse mixed cell lymphoma; adult diffuse small cleaved cell lymphoma; ... |
31. | | Recruiting | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Older Patients With Refractory or Relapsed Intermediate-Grade Non-Hodgkin's Lymphoma Conditions: recurrent grade 3 follicular lymphoma; recurrent adult diffuse small cleaved cell lymphoma; recurrent adult diffuse mixed cell lymphoma; ... |